Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
32,500
Employees32,500
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
32,500
Employees32,500

BMY Key Statistics

Market cap
125.59B
Market cap125.59B
Price-Earnings ratio
13.88
Price-Earnings ratio13.88
Dividend yield
3.98%
Dividend yield3.98%
Average volume
13.80M
Average volume13.80M
High today
$62.84
High today$62.84
Low today
$61.31
Low today$61.31
Open price
$62.77
Open price$62.77
Volume
9.76M
Volume9.76M
52 Week high
$68.64
52 Week high$68.64
52 Week low
$42.52
52 Week low$42.52

Stock Snapshot

With a market cap of 125.59B, Bristol-Myers Squibb(BMY) trades at $61.48. The stock has a price-to-earnings ratio of 13.88 and currently yields dividends of 3.98%.

On 2026-10-23, Bristol-Myers Squibb(BMY) stock traded between a low of $61.31 and a high of $62.84. Shares are currently priced at $61.48, which is +0.3% above the low and -2.2% below the high.

Bristol-Myers Squibb(BMY) shares are trading with a volume of 9.76M, against a daily average of 13.8M.

During the past year, Bristol-Myers Squibb(BMY) stock moved between $42.52 at its lowest and $68.64 at its peak.

During the past year, Bristol-Myers Squibb(BMY) stock moved between $42.52 at its lowest and $68.64 at its peak.

BMY News

Simply Wall St 3h
Why Did Bristol-Myers Squibb Climb Today?

The latest clinical news around Bristol-Myers Squibb (BMY) centers on late stage oncology and pulmonary fibrosis programs, featuring new Phase 3 readouts and a...

Bloomberg 7h
Bristol Myers Reports CAR-T Death as Safety Concerns Mount - Bloomberg.com

...

Bristol Myers Reports CAR-T Death as Safety Concerns Mount - Bloomberg.com
TipRanks 9h
Tempus AI Expands Neurology Data Partnership With Pathos

The latest update is out from Tempus AI, Inc. Class A ( (TEM) ). On October 23, 2026, Tempus AI announced a series of agreements with Bristol-Myers Squibb and...

Analyst ratings

58%

of 31 ratings
Buy
35.5%
Hold
58.1%
Sell
6.5%

More BMY News

Simply Wall St 1d
Bristol Myers Squibb Stock May Be 49% Undervalued Despite Phase 3 Wins

has delivered a 43.8% gain over the past year, and with the stock recently closing at US$61.12, the question for you is whether that move lines up with the cash...

Bristol Myers Squibb Stock May Be 49% Undervalued Despite Phase 3 Wins
The Motley Fool 3d
Have $1,000 to Invest? This Dirt Cheap Pharma Stock Pays You 4.2% to Wait.

Bristol Myers Squibb (BMY -1.54%) has one of the highest dividend yields among major pharmaceutical stocks. At current prices, its shares have a forward yield o...

Have $1,000 to Invest? This Dirt Cheap Pharma Stock Pays You 4.2% to Wait.
The Motley Fool 7d
Bristol-Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Healthcare remains a cornerstone for long-term investors, but choosing between a pure-play drugmaker and a diversified conglomerate is difficult. Is Bristol-Mye...

Bristol-Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.